Immunotherapy of malignant melanoma.
D000951:Antigens, Neoplasm / Q000008:administration & dosage; D001500:BCG Vaccine; D022121:Cholera Vaccines / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003606:Dacarbazine / Q000627:therapeutic use; D004137:Dinitrochlorobenzene; D004311:Double-Blind Method; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007372:Interferons / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D008545:Melanoma / Q000628:therapy*; D011897:Random Allocation; D012878:Skin Neoplasms / Q000628:therapy*; D012882:Skin Tests; D014165:Transfer Factor / Q000627:therapeutic use
D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D022121:Cholera Vaccines; D004137:Dinitrochlorobenzene; D014165:Transfer Factor; D007978:Levamisole; D003606:Dacarbazine; D007372:Interferons